SkyKnight Capital L P's Q2 2022 13F: 1 exit
Form 13F-HR for the quarter ended Jun 30, 2022 · filed Aug 2, 2022 · 3 reported positions · accession 0000950123-22-007661
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Increased | ADAPTHEALTH CORP (AHCO) | 91.7% | 94.6% | +2.9 pts | +760K sh | +9% |
| Exited | GINKGO BIOWORKS HOLDINGS INC (DNA) | 0.6% | — | −0.6 pts | −212K sh | −100% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 100.0% of the equity book
Changes in the top 10 this quarter: DNA left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | ADAPTHEALTH CORP (AHCO) | 91.7% | 94.6% | |
| 2 | LIBERTY GLOBAL PLC (LBTYK) | 5.5% | 3.9% | |
| 3 | LIBERTY GLOBAL PLC (LBTYA) | 2.2% | 1.5% | |
| — | GINKGO BIOWORKS HOLDINGS INC (DNA) | 0.6% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).